The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery

David A. Szalewski, Victoria S. Hinrichs, Denise K. Zinniel, Raul G Barletta

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The genus Aspergillus includes fungal species that cause major health issues of significant economic importance. These microorganisms are also the culprit for production of carcinogenic aflatoxins in grain storages, contaminating crops, and economically straining the production process. Aspergillus fumigatus is a very important pathogenic species, being responsible for high human morbidity and mortality on a global basis. The prevalence of these infections in immunosuppressed individuals is on the rise, and physicians struggle with the diagnosis of these deadly pathogens. Several virulence determinants facilitate fungal invasion and evasion of the host immune response. Metabolic functions are also important for virulence and drug resistance, since they allow fungi to obtain nutrients for their own survival and growth. Following a positive diagnostic identification, mortality rates remain high due, in part, to emerging resistance to frequently used antifungal drugs. In this review, we discuss the role of the main virulence, drug target, and drug resistance determinants. We conclude with the review of new technologies being developed to treat aspergillosis. In particular, microsphere and nanoparticle delivery systems are discussed in the context of improving drug bioavailability. Aspergillus will likely continue to cause problematic infections in immunocompromised patients, so it is imperative to improve treatment options.

Original languageEnglish (US)
Pages (from-to)439-453
Number of pages15
JournalCanadian journal of microbiology
Volume64
Issue number7
DOIs
StatePublished - Jan 1 2018

Fingerprint

Aspergillus fumigatus
Drug Resistance
Nanoparticles
Virulence
Aspergillus
Pharmaceutical Preparations
Immune Evasion
Aflatoxins
Aspergillosis
Mortality
Immunocompromised Host
Infection
Microspheres
Biological Availability
Fungi
Economics
Technology
Morbidity
Physicians
Food

Keywords

  • Antifungal drugs
  • Aspergillus fumigatus
  • Fungal pathogen
  • Invasive aspergillosis
  • Nanoparticle delivery systems

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Applied Microbiology and Biotechnology
  • Molecular Biology
  • Genetics

Cite this

The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery. / Szalewski, David A.; Hinrichs, Victoria S.; Zinniel, Denise K.; Barletta, Raul G.

In: Canadian journal of microbiology, Vol. 64, No. 7, 01.01.2018, p. 439-453.

Research output: Contribution to journalReview article

Szalewski, David A. ; Hinrichs, Victoria S. ; Zinniel, Denise K. ; Barletta, Raul G. / The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery. In: Canadian journal of microbiology. 2018 ; Vol. 64, No. 7. pp. 439-453.
@article{ae5fb51cd4f14453b942df07db628a47,
title = "The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery",
abstract = "The genus Aspergillus includes fungal species that cause major health issues of significant economic importance. These microorganisms are also the culprit for production of carcinogenic aflatoxins in grain storages, contaminating crops, and economically straining the production process. Aspergillus fumigatus is a very important pathogenic species, being responsible for high human morbidity and mortality on a global basis. The prevalence of these infections in immunosuppressed individuals is on the rise, and physicians struggle with the diagnosis of these deadly pathogens. Several virulence determinants facilitate fungal invasion and evasion of the host immune response. Metabolic functions are also important for virulence and drug resistance, since they allow fungi to obtain nutrients for their own survival and growth. Following a positive diagnostic identification, mortality rates remain high due, in part, to emerging resistance to frequently used antifungal drugs. In this review, we discuss the role of the main virulence, drug target, and drug resistance determinants. We conclude with the review of new technologies being developed to treat aspergillosis. In particular, microsphere and nanoparticle delivery systems are discussed in the context of improving drug bioavailability. Aspergillus will likely continue to cause problematic infections in immunocompromised patients, so it is imperative to improve treatment options.",
keywords = "Antifungal drugs, Aspergillus fumigatus, Fungal pathogen, Invasive aspergillosis, Nanoparticle delivery systems",
author = "Szalewski, {David A.} and Hinrichs, {Victoria S.} and Zinniel, {Denise K.} and Barletta, {Raul G}",
year = "2018",
month = "1",
day = "1",
doi = "10.1139/cjm-2017-0749",
language = "English (US)",
volume = "64",
pages = "439--453",
journal = "Canadian Journal of Microbiology",
issn = "0008-4166",
publisher = "National Research Council of Canada",
number = "7",

}

TY - JOUR

T1 - The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery

AU - Szalewski, David A.

AU - Hinrichs, Victoria S.

AU - Zinniel, Denise K.

AU - Barletta, Raul G

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The genus Aspergillus includes fungal species that cause major health issues of significant economic importance. These microorganisms are also the culprit for production of carcinogenic aflatoxins in grain storages, contaminating crops, and economically straining the production process. Aspergillus fumigatus is a very important pathogenic species, being responsible for high human morbidity and mortality on a global basis. The prevalence of these infections in immunosuppressed individuals is on the rise, and physicians struggle with the diagnosis of these deadly pathogens. Several virulence determinants facilitate fungal invasion and evasion of the host immune response. Metabolic functions are also important for virulence and drug resistance, since they allow fungi to obtain nutrients for their own survival and growth. Following a positive diagnostic identification, mortality rates remain high due, in part, to emerging resistance to frequently used antifungal drugs. In this review, we discuss the role of the main virulence, drug target, and drug resistance determinants. We conclude with the review of new technologies being developed to treat aspergillosis. In particular, microsphere and nanoparticle delivery systems are discussed in the context of improving drug bioavailability. Aspergillus will likely continue to cause problematic infections in immunocompromised patients, so it is imperative to improve treatment options.

AB - The genus Aspergillus includes fungal species that cause major health issues of significant economic importance. These microorganisms are also the culprit for production of carcinogenic aflatoxins in grain storages, contaminating crops, and economically straining the production process. Aspergillus fumigatus is a very important pathogenic species, being responsible for high human morbidity and mortality on a global basis. The prevalence of these infections in immunosuppressed individuals is on the rise, and physicians struggle with the diagnosis of these deadly pathogens. Several virulence determinants facilitate fungal invasion and evasion of the host immune response. Metabolic functions are also important for virulence and drug resistance, since they allow fungi to obtain nutrients for their own survival and growth. Following a positive diagnostic identification, mortality rates remain high due, in part, to emerging resistance to frequently used antifungal drugs. In this review, we discuss the role of the main virulence, drug target, and drug resistance determinants. We conclude with the review of new technologies being developed to treat aspergillosis. In particular, microsphere and nanoparticle delivery systems are discussed in the context of improving drug bioavailability. Aspergillus will likely continue to cause problematic infections in immunocompromised patients, so it is imperative to improve treatment options.

KW - Antifungal drugs

KW - Aspergillus fumigatus

KW - Fungal pathogen

KW - Invasive aspergillosis

KW - Nanoparticle delivery systems

UR - http://www.scopus.com/inward/record.url?scp=85049212753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049212753&partnerID=8YFLogxK

U2 - 10.1139/cjm-2017-0749

DO - 10.1139/cjm-2017-0749

M3 - Review article

C2 - 29586541

AN - SCOPUS:85049212753

VL - 64

SP - 439

EP - 453

JO - Canadian Journal of Microbiology

JF - Canadian Journal of Microbiology

SN - 0008-4166

IS - 7

ER -